Harvard Business Review
MAY 2, 2011
In 2009, the U.S. Another CEO of a fast-growing biotechnology venture, a Chinese-American entrepreneur, added that he wanted his company to be perceived as American rather than as Chinese. Haiyan Wang is the managing partner of the China India Institute. They are the authors of Getting China and India Right (Wiley, 2009).
Harvard Business Review
MARCH 1, 2011
And biotechnology and medical devices are among the leading areas for venture capital funding. The stimulus bill of 2009 allocated $30 billion for health care IT, and the Affordable Care Act of 2010 allowed significant changes in the way Medicare pays for services. Medicare payment policy favors doing more, not doing better.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Harvard Business Review
DECEMBER 30, 2011
That was the question Todd Pierce asked himself in 2006 after years of experimenting with the full menu of trainings, meetings, and competency models in his capacity as CIO of biotechnology giant Genentech. I remember sitting there and saying, 'There's got to be a another way.'".
Harvard Business Review
AUGUST 17, 2015
After 2009, the Cuban economy really didn’t recover. It could be an ideal location for healthcare organizations, but also for those in applied sciences, biotechnology, and pharmaceuticals. And secondly, the business model for Cuban biotechnology has been laughably bad. We know two things about biotech in Cuba.
Harvard Business Review
OCTOBER 22, 2013
When we surveyed over 300 global executives between 2008 and 2009, one of the primary concerns they expressed was their inability to compete long term without a solid innovation engine that can grow their top line. Finding ideas is never the problem — initially. The challenge is finding radical ideas consistently year after year.
Expert insights. Personalized for you.
14 
Let's personalize your content